Evaluation of YouControl-AFib, a mHealth Application for Persons With Atrial Fibrillation

NCT ID: NCT06575348

Last Updated: 2025-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-14

Study Completion Date

2025-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done to establish the feasibility of performing a clinical trial using a mHealth application named YouControl-AFib designed to improve the cardiovascular health of persons with atrial fibrillation. The study will obtain feedback on the app design to inform future versions and will collect preliminary data to support proof-of-concept and potential effect sizes for future trial design.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objective

* To effectively recruit participants for a clinical trial and obtain user feedback on the mHealth app using the Mobile App Rating Scale and focus group sessions.

Secondary Objectives

* To evaluate the impact of the YouControl-AFib mHealth app (pilot version, 3 months of use) on physical activity in persons with atrial fibrillation.
* To obtain several additional functional and disease specific endpoints that will help establish possible effect sizes to be evaluated more formally in subsequent versions of the mHealth application.
* To obtain user feedback on the mHealth app using the Mobile App Rating Scale and focus group sessions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

People using YouControl-A-Fib app

Group Type EXPERIMENTAL

YouControl-A-Fib mHealth Application

Intervention Type DEVICE

Participants will use the app for 3 months, includes 1 month phone call with Health Coach

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

YouControl-A-Fib mHealth Application

Participants will use the app for 3 months, includes 1 month phone call with Health Coach

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability to understand and the willingness to sign a written informed consent document
* Willing to comply with all study procedures and be available for the duration of the study
* SmartPhone capable of pairing with a Fitbit Sense 2 and Fitbit App (Apple iOS 15 and higher or Android 10 or higher)
* Paroxysmal or persistent atrial fibrillation verified by 12-lead electrocardiogram (ECG) or other clinical grade monitoring
* body mass index (BMI) greater than 27

Exclusion Criteria

* History of permanent atrial fibrillation
* Left ventricular ejection fraction (LVEF) less than 45 percent
* Myocardial infarction, coronary artery bypass grafting, or valve surgery within the last 12 months
* Moderate to severe valve disease
* Inability to participate in a structured exercise program due to musculoskeletal disease
* Already participating in a structured exercise program or achieving guideline directed physical activity
* Planned surgery or procedure during the next three months that limit ability to engage in physical activity
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for Advancing Translational Sciences (NCATS)

NIH

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthew M Kalscheur, MD

Role: PRINCIPAL_INVESTIGATOR

UW School of Medicine and Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UW School of Medicine and Public Health

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Attia ZI, Friedman PA, Noseworthy PA, Lopez-Jimenez F, Ladewig DJ, Satam G, Pellikka PA, Munger TM, Asirvatham SJ, Scott CG, Carter RE, Kapa S. Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs. Circ Arrhythm Electrophysiol. 2019 Sep;12(9):e007284. doi: 10.1161/CIRCEP.119.007284. Epub 2019 Aug 27.

Reference Type BACKGROUND
PMID: 31450977 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A534225

Identifier Type: OTHER

Identifier Source: secondary_id

Protocol Version 8/6/2024

Identifier Type: OTHER

Identifier Source: secondary_id

1UL1TR002373

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2024-0954

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.